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ABSTRACT
The recent discovery of genomic 5-hydroxy-
methylcytosine (hmC) and mutations affecting the
respective Tet hydroxylases in leukemia raises
fundamental questions about this epigenetic modi-
fication. We present a sensitive method for fast
quantification of genomic hmC based on specific
transfer of radiolabeled glucose to hmC by a
purified glucosyltransferase. We determined hmC
levels in various adult tissues and differentiating
embryonic stem cells and show a correlation with
differential expression of tet genes.
INTRODUCTION
DNA methylation plays a crucial role in the epigenetic
regulation of gene expression during development and
disease (1). The post-replicative addition of a methyl
group to the carbon-5 of cytosine has long been the only
known enzymatic modiﬁcation to bases in mammalian
genomic DNA, and due to its crucial role as an epigenetic
mark it is often referred to as the ﬁfth base. Recently, the
Ten-Eleven Translocation 1 gene (tet1) was shown to
encode a 2-ketoglutarate- and Fe(II)-dependant
hydroxylase that converts genomic 5-methylcytosine
(mC) to 5-hydroxymethylcytosine (hmC) and on the
basis of sequence homology the closely related Tet2 and
3 proteins are expected to catalyze the same reaction (2,3).
To date hmC has been detected in genomic DNA isolated
from embryonic stem cells (ESCs) and some adult tissues
and it appears to be relatively abundant in the central
nervous system (2,4–6). The functional relevance of hmC
in these tissues is unknown and roles as an epigenetic
mark and/or an intermediate of oxidative demethylation
are intriguing possibilities (2,7). In addition,
translocations as well as nonsense and missense mutations
of tet genes have been identiﬁed in myelodysplastic syn-
dromes including several forms of myeloid leukemia
(8–10), raising the possibility that aberrant genomic
hmC patterns may be involved in these pathologies.
These observations grant sustained efforts to deﬁne the
role(s) of hmC in mammalian genomes.
Quantiﬁcation and selective detection of genomic hmC
is technically challenging due to the relatively low abun-
dance and similarity of hmC to the more abundant mC,
not only in structural terms but also with respect to lack of
deamination by bisulﬁte treatment (11–12). We sought to
exploit enzymes involved in hmC modiﬁcation that
evolved as part of the struggle between prokaryotes and
their viruses.
The three methods used so far to quantify global hmC
content in mammalian genomes are designed to detect
hmC in hydrolyzed DNA globally (HPLC/esi-ms/ms) or
at subsets of CpG sites (2,4,5). As hmC may also occur at
non-CpG sites, the latter type of methods may underesti-
mate its abundance. In addition, none of these procedures
is easily applicable to large sample numbers. We therefore
sought to establish a highly sensitive and accurate method
to detect hmC independently of sequence context and with
higher throughput capacity. To this aim, we turned our
attention to glucosyltransferases of T-even bacteriophages
that transfer glucose from UDP-glucose donor to genomic
hmC. Notably, all cytosines in the T4 genome are replaced
by hmC residues that are invariably modiﬁed by a- and
b-glucosyltransferases (a- and b-gt; Figure 1A). We
reasoned that by using UDP-[
3H]glucose the incorpor-
ation of radiolabeled glucose in DNA should reﬂect the
abundance of hmC. We focused on b-gt rather than a-gt,
as it was shown to glucosylate to completion all tested
hmC-containing DNA substrates both in vivo and
in vitro, including the non-glucosylated T4 genome
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MATERIALS AND METHODS
Cell culture and differentiation of ESCs
Undifferentiated J1 and E14 ESCs were maintained on
gelatin-coated dishes in Dulbecco’s modiEed Eagle’s
medium containing 16% fetal bovine serum (PAA
Laboratories GmbH), 0.1mM b-mercaptoethanol
(Invitrogen), 2mM L-glutamine, 1 MEM Non-essential
Amino Acid Solution, 100U/ml penicillin, 100mg/ml
streptomycin (PAA Laboratories GmbH) and 1000U/ml
recombinant mouse LIF (Millipore). To induce embryoid
body (EB) formation, ESCs were resuspended in the
same medium as above but without LIF and cultured
in hanging drops (600cells/20ml drop) for 4 days.
Subsequently, EBs were cultured in bacterial culture
dishes and the medium was replaced every 4 days.
DNA and RNA isolation
All tissue samples were prepared from 6-week-old 129sv
mice. Genomic DNA and total RNA were isolated
from tissue samples using the NucleoSpin Triprep Kit
(Macherey-Nagel). Genomic DNA and total RNA were
isolated from ESCs and EBs using the Blood & Cell
culture DNA mini kit (QIAGEN) and TRIzol reagent
(Invitrogen), respectively. To avoid genomic DNA con-
tamination, isolated RNA was digested with recombinant
RNase-free DNase I (Roche) and further puriﬁed with the
QIAGEN RNeasy kit. Genomic DNA samples were
sheared to 500–1500bp fragments by sonication to
reduce the viscosity and improve homogeneity. The con-
centration of genomic DNA samples was measured by
ﬂuorometry. Fifty microliters of diluted sample were
mixed with 50mlo f2 TNE (Tris 20mM, pH 7.4; NaCl
400mM and EDTA 2mM) containing 200ng/mlo f
Hoechst 33258. Fluorescence was measured in a
TECAN inﬁnite M1000 plate reader (Ex: 350/10; Em:
455/10). Serial dilutions (20–2000ng/ml) of the hmC con-
taining reference DNA fragment (see below) were used as
standard for quantiﬁcation.
Protein expression and puriﬁcation
The sequence encoding bacteriophage T4 b-gt was
synthesized at Mr. Gene GmbH (Regensburg) and cloned
into pET28b vector (Novagen). BL21(DE3) E. coli cells
carrying the expression construct were grown at 37 C
until A600=0.6–0.7 and induced with 1mM isopropyl
b-D-thiogalactopyranoside for 16h at 20 C. Lysates were
prepared by sonication in 300mM NaCl, 50mM
Na2HPO4, 10mM imidazole, 1mM b-mercaptoethanol,
cleared by centrifugation and applied to nickel-
nitrilotriacetic acid column (QIAGEN) pre-equilibrated
with lysis buffer. Washing and elution were performed
with lysis buffer containing 20 and 250mM imidazole,
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Figure 1. Elements of the hmC glucosylation assay. (A) Schematic representation of the hmC glucosylation reaction catalyzed by b-gt.
(B) Coomassie blue stained gel showing the puriﬁed b-gt preparation. (C) Example of calibration curve using mixtures of hmC-containing and
unmodiﬁed reference fragment (equal total DNA amounts). Note the linear relationship between [
3H]glucose incorporation and percentage of hmC.
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S-200 preparative gel ﬁltration column (GE Healthcare)
in 150mM NaCl, 20mM Tris, pH 8.0, 1mM DTT.
Fractions containing the b-gt peak were pooled and
applied to a ResourceQ anion exchange column (GE
Healthcare) in order to eliminate residual contaminants,
resulting in pure b-gt in the ﬂowthrough.
Preparation of reference DNA fragments
Reference DNA fragments (1139bp) containing 0 and
100% hmC were prepared by polymerase chain reaction
(PCR), using dCTP and 5-hydroxymethyl-dCTP (Bioline
GmbH), respectively. T4 phage DNA was used as
template with primers: 50-TGG AGA AGG AGA ATG
AAG AAT AAT-30 and 50-GTG AAG TAA GTA ATA
AAT GGA TTG-30, Phusion HF DNA Polymerase
(Finnzymes) and the following cycling proﬁle: one cycle
of 98 C for 2min and 35 cycles of 98 C for 10s; 58 C for
10s; and 72 C for 30s. Primer sequences were selected
that do not contain cytosine residues. PCR products
were puriﬁed by gel electrophoresis followed by silica
column puriﬁcation (Nucleospin, Macherey-Nagel).
Quantitative hmC glucosylation assay
Reactions contained 150mM NaCl, 20mM Tris, pH 8.0,
25mM CaCl2, 1mM DTT, 2.8mM ‘cold’ UDP-glucose
(Sigma-Aldrich), 0.86nM UDP-[
3H]glucose (glucose-
6-
3H; 60Ci/mmol; Hartmann Analytic GmbH), 1mgo f
DNA substrate and 36nM recombinant b-gt in a total
volume of 50ml. Reactions were incubated for 20min at
room temperature and terminated by heating at 65 C for
10min. Twenty microliters of each reaction were spotted
in duplicate on paper ﬁlters (Whatmann) and DNA was
precipitated by incubation in 5% TCA for 15min at room
temperature. Filters were washed twice with 5% TCA and
once with 70% ethanol. Remaining radioactivity was
measured using a Liquid Scintillation Analyzer Tri-Carb
2100TR (Packard) with quench indicating parameter set
on tSIE/AEC (transformed spectral index of the external
standard/automatic efﬁciency control) in 4ml of Rotiszint
Eco Plus scintillation liquid (Roth GmbH) in Snaptwist
vials (Simport). Samples were measured for 30min or until
the 2 value reached 2%. The percentage of hmC per total
cytosine was calculated from the incorporation of
[
3H]glucose using a calibration curve measured with the
reference fragment series for every experiment. The per-
centage of hmC was then corrected for the difference in C
abundance between reference fragment (35%) and mouse
genome (42%).
cDNA synthesis and real-time PCR
Five hundred nanograms of total RNA were used for
cDNA synthesis with the High-Capacity cDNA Reverse
Transcription Kit (with RNase Inhibitor; Applied
Biosystems). Equal amounts of cDNA were used for
real-time PCR with Power SYBR Green PCR Master
Mix (Applied Biosystems) on a 7500 Fast Real-Time
PCR System (Applied Biosystems) according to the manu-
facturer’s instructions. Gene expression levels were
normalized to Gapdh and calculated using the compara-
tive CT method (CT method).
Primers for quantitative real-time PCR were designed
with the Primer Express software (Applied Biosystems)
and contained the following sequences: Gapdh forward
50-CAT GGC CTT CCG TGT TCC TA-30, Gapdh
reverse 50-CTT CAC CAC CTT CTT GAT GTC
ATC-30, Tet1 forward 50-CCA GGA AGA GGC GAC
TAC GTT-30, Tet1 reverse 50-TTA GTG TTG TGT
GAA CCT GAT TTA TTG T-30, Tet2 forward 50-ACT
TCT CTG CTC ATT CCC ACA GA-30, Tet2 reverse
50-TTA GCT CCG ACT TCT CGA TTG TC-30, Tet3
forward 50-GAG CAC GCC AGA GAA GAT CAA-30
and Tet3 reverse 50-CAG GCT TTG CTG GGA CAA
TC-30.
RESULTS AND DISCUSSION
T4 b-gt was expressed in bacteria as a 6   His tag fusion
and puriﬁed to homogeneity by sequential nickel-NTA,
size exclusion and ion exchange chromatography
(Figure 1B). To assess whether transfer of [
3H]glucose to
DNA is proportional to the hmC content within the range
previously reported for mammalian tissues, we prepared a
series of standard DNA substrate samples with global
hmC content ranging from 0.25 to 2% of total cytosine
by mixing corresponding proportions of two preparations
of the same 1.2kb DNA fragment, one having all cytosine
residues replaced by hmC and the other containing no
hmC (Figure 1C). Using a 325-fold excess of unlabelled
UDP-glucose, the incorporation of radiolabeled glucose in
1mg of total DNA substrate was strictly linear in this
range. This standard sample series was measured in
every assay to generate a calibration curve for the calcu-
lation of hmC content in genomic DNA samples. We ﬁrst
measured genomic hmC levels in wild-type and Dnmt1, 3a
and 3b triple knockout (TKO) J1 ESCs (15) (Figure 2A
and B). Due to the absence of all three major DNA
methyltransferases, genomic DNA from TKO ESCs is
expected to contain very little, if any, cytosine methyla-
tion. Indeed, the measured level of genomic hmC in TKO
ESCs was at the detection limit (0.025%) of our assay,
while genomic DNA from wild-type ESCs contained
0.3% hmC relative to total cytosine. Real-time reverse
transcription (RT) PCR analysis showed that Tet1–3
mRNA levels are similar in wild-type and TKO ESCs,
with Tet1 transcripts largely preponderant and Tet3
mRNA the least abundant (more than 40-fold lower
than Tet1). It was previously shown that differentiation
of mouse ESCs by withdrawal of LIF from monolayer
cultures for 5 days results in a reduction of genomic
hmC and concomitant decrease in Tet1 transcripts (2).
We followed genomic hmC and Tet1–3 transcript
dynamics during EB differentiation of two commonly
used wild-type ESC lines (Figure 2A and B and
Supplementary Figure S1). In both cases, a sharp
decrease of hmC content was evident after 4 days of EB
culture, but a substantial recovery was observed after add-
itional 4 days of culture (Day 8). Interestingly, the tet
genes showed distinct expression dynamics during ESCs
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in the ﬁrst 4 days and further dropped by Day 8 of EB
culture. Tet2 mRNA levels also decreased in the ﬁrst
4 days, but were fully restored in Day 8 EBs.
In contrast, Tet3 transcripts doubled at Day 4 and in-
creased about 20 times by Day 8 of EB culture. Thus,
the relatively high hmC content in undifferentiated ESCs
correlates with high levels of Tet1 and, to a lower extent,
Tet2 transcripts, while the partial recovery of genomic
hmC in Day 8 EBs correlates with increased Tet2 and
Tet3 mRNA levels.
We then analyzed several adult mouse tissues
(Figure 2C and D). As reported earlier, the highest
levels of genomic hmC were found in brain regions,
although kidney also showed relatively high levels. In all
cases, the hmC content was at least four times higher than
the detection limit, while in a previous report using a dif-
ferent assay the same non-neural tissues were either mar-
ginally above or right at the detection limit (5). Abundant
hmC in brain tissues correlated with high levels of Tet3
and to a lower extent Tet2, a pattern similar to Day 8 EBs.
Thus, most differentiated tissues are characterized by very
low levels of Tet1 and high levels of Tet3, while undiffer-
entiated ESCs show the opposite pattern. It will be
interesting to determine whether all pluripotent cell types
have this pattern and at which stages along the speciﬁca-
tion of the various somatic lineages the relative expression
levels of tet genes change. Interestingly, kidney represents
an exception among the adult tissues analyzed as it shows
relatively high hmC content and a prevalence of Tet2 tran-
scripts. This is consistent with a cellular defect in proximal
convoluted tubules of the kidney as the only phenotype
described for Tet2 null mice (16). These observations
suggest that Tet proteins have redundant roles and that
the lack of a speciﬁc Tet family member may result in
phenotypic alterations only in tissues where high levels
of that Tet enzyme cannot be compensated by the other
family members. In this context, it should be noted
that the assay described here could also be employed to
measure the enzymatic activity of Tet proteins and their
mutants identiﬁed in leukemia patients by using mC-
containing DNA substrates.
In conclusion, we have established an accurate assay for
the quantiﬁcation of genomic hmC that: (i) is more sensi-
tive than previously described methods; (ii) is not subject
to sequence bias; (iii) allows simultaneous processing of
large sample numbers; and (iv) does not require
specialized and expensive equipment. It should be noted
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Figure 2. Quantiﬁcation of genomic hmC and Tet transcripts in mouse tissues, undifferentiated ESCs and EBs. (A and C) hmC glucosylation assays.
The percentage of hmC per total cytosine was calculated from the incorporation of [
3H]glucose using a calibration curve from the reference fragment
(see Figure 1C). Shown are average values and error bars from two (A) or one (C) biological replicates, each measured in two independent assays,
with the exception of hippocampus that was measured only once. In every assay, each sample was measured in duplicate. The dashed line in
(A) indicates the estimated limit of detection. (B and D) Real-time RT–PCR analysis for Tet transcript levels. Expression levels are all relative to
Tet1 in kidney (set to 1), so that values in b and d are directly comparable. Shown are average values and error bars from two (B) and one
(D) biological replicates, each measured from two independent cDNA synthesis reactions. In every real-time PCR reaction, each sample was
measured in triplicate. Genomic DNA and RNA samples used in A/C and B/C, respectively, were isolated from the very same cell and tissue lysates.
e181 Nucleic Acids Research, 2010,Vol.38, No. 19 PAGE 4 OF 5that lower concentrations of ‘cold’ UDP-glucose should
allow scaling down the amount of substrate DNA
without loss of signal. This assay will be highly useful to
determine the global abundance of hmC in genomic DNA,
especially in situations where limited amounts of tissue are
available such as isolates of rare primary cell types and
clinical samples.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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